General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-08 | 2024-01 | 0 | -0.01 | N/A | N/A |
2023-12-07 | 2023-10 | 0 | 0.01 | N/A | N/A |
2023-09-14 | 2023-07 | 0 | N/A | N/A | N/A |
2023-06-14 | 2023-04 | 0 | 0.03 | N/A | N/A |
2023-05-02 | 2023-01 | 0 | 0.02 | N/A | N/A |
2022-12-14 | 2022-10 | 0 | 0.01 | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2017-01-23 | BARNHILL PAMELA J | President | 252.44K | Stock Award(Grant) |
2017-01-23 | BERG MARC E | Officer and Director | 63.48K | Stock Award(Grant) |
2024-01-23 | CHASE J R | Trustee | 73.46K | Purchase |
2017-01-23 | KETCHERSIDE CYNTHIA | Director | 23.15K | Stock Award(Grant) |
2018-03-15 | KUTASI LESLIE T | Director | 36.00K | Stock Award(Grant) |
2015-12-21 | PELEGRIN LARRY | Director | 103.21K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Renaissance Technologies, LLC | 113.30K | 270.79K | 1.26% |
2023-06-29 | Vanguard Group Inc | 51.41K | 122.87K | 0.57% |
2023-06-29 | Geode Capital Management, LLC | 30.13K | 72.02K | 0.33% |
2023-06-29 | State Street Corporation | 19.27K | 46.07K | 0.21% |
2023-06-29 | Carnegie Mellon University | 10.00K | 23.90K | 0.11% |
2023-06-29 | Tower Research Capital LLC (TRC) | 3.86K | 9.21K | 0.04% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 51.41K | 122.87K | 0.57% |
2023-05-30 | Fidelity Extended Market Index Fund | 26.85K | 48.32K | 0.30% |
2023-05-30 | Fidelity Series Total Market Index Fund | 2.04K | 3.68K | 0.02% |
Dividend | Date |
---|---|
0.01 | 2024-01-19 |
0.01 | 2023-07-19 |
0.01 | 2022-01-14 |
0.01 | 2021-07-14 |
0.01 | 2021-01-14 |
0.01 | 2020-07-15 |
It’s been halted.... get ready for takeoff!!
Hitting 6!
Holding up very well, has great support for a big move Up to mid 4s
Hello! anyone home? Did everyone go on vacation?
With all news of Vaccine and more cases, i finally come to the conclusion it’s just a bunch a end of the pipeline BS
Another Vaccine approval and MAX737 flying again. This is great.
History $IBIO was built for pandemic purposes in 2010 by DARPA. In 2011 the influenza disease outbreak happened and IBIO hit their peak as a company. Then the disease died out and so did their stock price. In 2014, the outbreak of Ebola happened and so they hit another peak. Now look where we’re at now.Covid is destroying the world in many ways and people are seeing how big this has effected the world so far. IBIO was built for this exact reason. In my opinion, influenza became less dangerous as scientists have developed vaccines and the spread of Ebola died out. COVID will not die for months/years to come. $IBIO shares price in past pandemics 15$-55$, $IBIO is known for FastPharming has applications far beyond producing a COVID-19 vaccine. An example of this potential was a deal signed in October with Safi Biosolutions. The agreement will see iBio’s FastPharming system used in the bioprocessing of Safi’s blood cell therapy products. FastPharming has the potential to be part of many such deals in the future. $IBIO conference is Today (there are speculation of possible contract or partnership)